VDValeria Dominelli

Valeria Dominelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valeria Dominelli has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Explainable Artificial Intelligence in Mammography: A Systematic Review of Methods, Evaluation Practices, and Clinical Readiness

    by Filippo Pesapane, Anna Rotili, Silvia Penco, Valeria Dominelli, Francesca Priolo, Irene Marinucci, Luca Nicosia, Roberto Grasso, Gabriella Pravettoni, Enrico Cassano

    Background: Explainable artificial intelligence (XAI) is increasingly proposed to improve trust in mammography-based artificial-intelligence systems, but the validity and clinical readiness of published explanations remain unclear. We aim to systematically review XAI methods applied to mammography and synthesize how explanations are evaluated for validity, robustness, and clinical usefulness. Methods: We conducted a systematic review according to PRISMA 2020. MEDLINE/PubMed, Embase, Scopus, Web of Science Core Collection, and the Cochrane Library were searched from 1 January 2015 to 15 January 2026. Two reviewers independently screened records and extracted data; disagreements were resolved by consensus with a third reviewer. Included studies used mammography as the primary input and reported an explicit explanation or interpretability mechanism. Because the literature was methodologically heterogeneous, we performed a structured narrative synthesis and an adapted XAI-specific appraisal of explanation claims, quantitative evaluation, external validation, human-factor assessment, and reporting transparency. Results: Fourteen studies were included. Ten studies addressed detection or lesion classification and four addressed risk or outcome prediction. Primary XAI families were interpretable-by-design architectures (6/14), post hoc saliency or attribution methods (5/14), and feature-level explanation methods (3/14). Five studies remained at tier-1 qualitative plausibility only, seven reached tier-2 internal quantitative explanation evaluation, two reached tier-3 external or cross-dataset interpretability assessment, and none reported reader or workflow studies. In the dedicated mammography saliency benchmark, Pointing Game scores for Grad-CAM, Grad-CAM++, and Eigen-CAM ranged from 0.30 to 0.41, indicating only modest lesion-pointing reliability despite acceptable classifier performance. Conclusions: Mammography XAI remains dominated by visually plausible explanations that are inconsistently validated. The literature is moving toward task-aligned and intrinsically interpretable designs, yet external validation and clinician-centered evaluation remain rare. Future studies should pre-specify explanation claims, use task-appropriate quantitative metrics, report explanation robustness under distribution shift, and test whether explanations improve human decision-making.


  • Open Access

    Artificial Intelligence-Driven Personalization in Breast Cancer Screening: From Population Models to Individualized Protocols

    by Filippo Pesapane, Luca Nicosia, Lucrezia D’amelio, Giulia Quercioli, Mariassunta Roberta Pannarale, Francesca Priolo, Irene Marinucci, Maria Giorgia Farina, Silvia Penco, Valeria Dominelli, et al.

    Conventional breast cancer screening programs are predominantly age-based, applying uniform intervals and modalities across broad populations. While this model has reduced mortality, it entails harms—including overdiagnosis, false positives, and missed interval cancers—prompting interest in risk-stratified approaches. In recent years, artificial intelligence (AI) has emerged as a critical enabler of this paradigm shift. This narrative review examines how AI-driven tools are advancing breast cancer screening toward personalization, with a focus on mammographic risk models, multimodal risk prediction, and AI-enabled clinical decision support. We reviewed studies published from 2015 to 2025, prioritizing large cohorts, randomized trials, and prospective validations. AI-based mammographic risk models generally improve discrimination versus classical models and are being externally validated; however, evidence remains heterogeneous across subtypes and populations. Emerging multimodal models integrate genetics, clinical data, and imaging; AI is also being evaluated for triage and personalized intervals within clinical workflows. Barriers remain—explainability, regulatory validation, and equity. Widespread adoption will depend on prospective clinical benefit, regulatory alignment, and careful integration. Overall, AI-based mammographic risk models generally improve discrimination versus classical models and are being externally validated; however, evidence remains heterogeneous across molecular subtypes, with signals strongest for ER-positive disease and limited data for fast-growing and interval cancers. Prospective trials demonstrating outcome benefit and safe interval modification are still pending. Accordingly, adoption should proceed with safeguards, equity monitoring, and clear separation between risk prediction, lesion detection, triage, and decision-support roles


  • Open Access

    Machine and Deep Learning on Radiomic Features from Contrast-Enhanced Mammography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Breast Cancer Characterization

    by Roberta Fusco, Vincenza Granata, Teresa Petrosino, Paolo Vallone, Maria Assunta Daniela Iasevoli, Mauro Mattace Raso, Sergio Venanzio Setola, Davide Pupo, Gerardo Ferrara, Annarita Fanizzi, et al.

    Objective: The aim of this study was to evaluate the accuracy of machine and deep learning approaches on radiomics features obtained by Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and contrast enhanced mammography (CEM) in the characterization of breast cancer and in the prediction of the tumor molecular profile. Methods: A total of 153 patients with malignant and benign lesions were analyzed and underwent MRI examinations. Considering the histological findings as the ground truth, three different types of findings were used in the analysis: (1) benign versus malignant lesions; (2) G1 + G2 vs. G3 classification; (3) the presence of human epidermal growth factor receptor 2 (HER2+ vs. HER2−). Radiomic features (n = 851) were extracted from manually segmented regions of interest using the PyRadiomics platform, following IBSI-compliant protocols. Highly correlated features were excluded, and the remaining features were standardized using z-score normalization. A feature selection process based on Elastic Net regularization (α = 0.5) was used to reduce dimensionality. Synthetic balancing of the training data was applied using the ROSE method to address class imbalance. Model performance was evaluated using repeated 10-fold cross-validation and AUC-based metrics. Results: Among the 153 patients enrolled in the studies, 113 were malignant lesions. Among the 113 malignant lesions, 32 had high grading (G3) and 66 had the HER2+ receptor. Radiomic features derived from both CEM and DCE-MRI showed strong discriminative performance for malignancy detection, with several features achieving AUCs above 0.80. Gradient Boosting Machine (GBM) achieved the highest accuracy (0.911) and AUC (0.907) in differentiating benign from malignant lesions. For tumor grading, the neural network model attained the best accuracy (0.848), while LASSO yielded the highest sensitivity (0.667) for detecting high-grade tumors. In predicting HER2+ status, the neural network also performed best (AUC = 0.669), with a sensitivity of 0.842. Conclusions: Radiomics-based machine learning models applied to multiparametric CEM and DCE-MRI images offer promising, non-invasive tools for breast cancer characterization. The models effectively distinguished benign from malignant lesions and showed potential in predicting histological grade and HER2 status. These results demonstrate that radiomic features extracted from CEM and DCE-MRI, when analyzed through machine and deep learning models, can support accurate breast cancer characterization. Such models may assist clinicians in early diagnosis, histological grading, and biomarker assessment, potentially enhancing personalized treatment planning and non-invasive decision-making in routine practice.


  • Open Access

    Ultrafast Breast MRI: A Narrative Review

    by Ottavia Battaglia, Filippo Pesapane, Silvia Penco, Giulia Signorelli, Valeria Dominelli, Luca Nicosia, Anna Carla Bozzini, Anna Rotili, Enrico Cassano

    Breast magnetic resonance imaging (MRI) is considered the most effective method for detecting breast cancer due to its high sensitivity. Yet multiple factors limit its widespread use, including high direct and indirect costs, a prolonged acquisition time with consequent patient discomfort, and a lack of trained radiologists. During the last decade, new strategies have been followed to increase the availability of breast MRI, including the omission of non-essential sequences to generate abbreviated MRI protocols (AB-MRIs) aimed at reducing the acquisition time with the potential of improving the patient’s experience and accommodating a higher number of MRI examinations per day. An alternative method is ultrafast MRI (UF-MRI), a novel technique that gathers kinetic data within the first minute after contrast injection, offering high temporal resolution. This enables the analysis of early contrast wash-in curves, showing promising outcomes. In this study, we reviewed the role of UF-MRI in breast imaging and detailed how the integration of this new approach with radiomics and mathematical models might further improve diagnostic accuracy and even have a prognostic role, a fundamental characteristic in the modern scenarios of personalized medicine. In addition, possible clinical applications and advantages of UF-MRI will be discussed.


  • Open Access

    Contrast Agents in Breast MRI: State of the Art and Future Perspectives

    by Filippo Pesapane, Adriana Sorce, Ottavia Battaglia, Carmen Mallardi, Luca Nicosia, Luciano Mariano, Anna Rotili, Valeria Dominelli, Silvia Penco, Francesca Priolo, et al.

    Contrast-enhanced magnetic resonance imaging (CE-MRI) has become an essential modality in breast cancer diagnosis and management. It is particularly used for locoregional staging, high-risk screening, monitoring treatment response, and assessing complications related to breast implants. The integration of gadolinium-based contrast agents (GBCAs) enhances the sensitivity and specificity of CE-MRI by providing detailed morphological and functional insights, particularly highlighting tumor neoangiogenesis. Despite its advantages, CE-MRI faces challenges such as high costs, limited accessibility, and concerns about gadolinium retention in tissues, prompting ongoing research into safer, high-relaxivity contrast agents like gadopiclenol. Advances in multiparametric imaging, including dynamic contrast-enhanced sequences and diffusion-weighted imaging, have refined diagnostic accuracy, enabling precise staging, and treatment planning. The introduction of abbreviated breast MRI (AB-MRI) protocols offers a promising solution to barriers of cost and scan duration, maintaining diagnostic efficacy while improving patient accessibility and comfort. Future innovations in contrast agents, imaging protocols, and patient-centered approaches hold the potential to further enhance the utility of breast MRI, ensuring equitable and effective application in global healthcare systems.


  • Open Access

    A preliminary investigation into the potential, pitfalls, and limitations of large language models for mammography interpretation

    by Filippo Pesapane, Luca Nicosia, Anna Rotili, Silvia Penco, Valeria Dominelli, Chiara Trentin, Federica Ferrari, Giulia Signorelli, Serena Carriero, Enrico Cassano

    This study evaluates the capabilities of large language models, specifically GPT-4, in interpreting mammographic images. The analysis involved 120 mammographic images equally divided between cases with and without mammography’s findings. Without additional context, the LLM was tasked to generate reports based solely on these images. GPT-4 correctly identified mammographic projections in 53.3% of cases and showed varying degrees of accuracy in identifying microcalcifications and masses. The study highlighted GPT-4’s embryonic interpretative abilities with a sensitivity of 50.0% and specificity of 37.5%. However, a significant rate of false positives and false negatives, along with hallucinations, underscored the model's limitations. This exploratory test offers insights into the potential and risks of using LLMs in mammography interpretation, also underscoring the need for dedicated training, validation, and regulation of AI tools in healthcare to ensure their reliability and safety in clinical practice.


  • Retrospective study on the strength of magnetic resonance signs for predicting breast implant rupture: assessing the impact of radiologist expertise at a breast cancer referral center

    by Filippo Pesapane, Anna Rotili, Giulia Signorelli, Valeria Dominelli, Luca Mazzocconi, Adriana Sorce, Ottavia Battaglia, Giovanni Cugliari, Sara Gandini, Luca Nicosia, et al.

    Objective This study evaluates the diagnostic criteria of MRI for breast implant rupture and examines the influence of radiologist experience on the accuracy of rupture detection. Methods A retrospective study was conducted in a single center, involving patients who underwent implant replacement surgery between March 2019 and October 2022. MRI evaluations by four radiologists of varying experience levels were compared with surgical outcomes. Results The study included 118 explanted prostheses, with 25 identified as ruptured. Expert radiologists demonstrated near-perfect agreement (κ = 0.94) in identifying rupture signs, with high PPV and NPV, whereas non-experts showed only moderate agreement (κ = 0.44). Indicators such as the linguine sign, subcapsular line, and keyhole sign were identified with high accuracy by experts, contrasting with non-experts’ lower detection rates. Conclusions Expertise in radiology significantly impacts the accurate diagnosis of breast implant ruptures. This study supports updating radiological guidelines and underscores the importance of specialized training and experience in improving diagnostic outcomes in breast implant assessments.


  • Open Access

    Radiological Features of Male Breast Neoplasms: How to Improve the Management of a Rare Disease

    by Luca Nicosia, Luciano Mariano, Anna Carla Bozzini, Filippo Pesapane, Vincenzo Bagnardi, Samuele Frassoni, Chiara Oriecuia, Valeria Dominelli, Antuono Latronico, Simone Palma, et al.

    The primary aim of our study was to assess the main mammographic and ultrasonographic features of invasive male breast malignancies. The secondary aim was to evaluate whether a specific radiological presentation would be associated with a worse receptor profile. Radiological images (mammography and/or ultrasound) of all patients who underwent surgery for male invasive breast cancer in our institution between 2008 and 2023 were retrospectively analyzed by two breast radiologists in consensus. All significant features of radiological presentation known in the literature were re-evaluated. Fifty-six patients were selected. The mean age at surgery of patients was 69 years (range: 35–81); in 82% of cases (46 patients), the histologic outcome was invasive ductal carcinoma. A total of 28 out of 56 (50%) patients had preoperative mammography; in 9/28 cases (32%), we found a mass with microcalcifications on mammography. The mass presented high density in 25 out of 28 patients (89%); the mass showed irregular margins in 15/28 (54%) cases. A total of 46 out of 56 patients had preoperative ultrasounds. The lesion showed a solid mass in 41/46 (89%) cases. In 5/46 patients (11%), the lesion was a mass with a mixed (partly liquid–partly solid) structure. We did not find any statistically significant correlation between major types of radiological presentation and tumor receptor arrangement. Knowledge of the main radiologic presentation patterns of malignant male breast neoplasm can help better manage this type of disease, which is rare but whose incidence is increasing.


  • Open Access

    How Radiomics Can Improve Breast Cancer Diagnosis and Treatment

    by Filippo Pesapane, Paolo De Marco, Anna Rapino, Eleonora Lombardo, Luca Nicosia, Priyan Tantrige, Anna Rotili, Anna Carla Bozzini, Silvia Penco, Valeria Dominelli, et al.

    Recent technological advances in the field of artificial intelligence hold promise in addressing medical challenges in breast cancer care, such as early diagnosis, cancer subtype determination and molecular profiling, prediction of lymph node metastases, and prognostication of treatment response and probability of recurrence. Radiomics is a quantitative approach to medical imaging, which aims to enhance the existing data available to clinicians by means of advanced mathematical analysis using artificial intelligence. Various published studies from different fields in imaging have highlighted the potential of radiomics to enhance clinical decision making. In this review, we describe the evolution of AI in breast imaging and its frontiers, focusing on handcrafted and deep learning radiomics. We present a typical workflow of a radiomics analysis and a practical “how-to” guide. Finally, we summarize the methodology and implementation of radiomics in breast cancer, based on the most recent scientific literature to help researchers and clinicians gain fundamental knowledge of this emerging technology. Alongside this, we discuss the current limitations of radiomics and challenges of integration into clinical practice with conceptual consistency, data curation, technical reproducibility, adequate accuracy, and clinical translation. The incorporation of radiomics with clinical, histopathological, and genomic information will enable physicians to move forward to a higher level of personalized management of patients with breast cancer.